MARVIN DONALD (Executive VP, CFO & COO) purchased 33.3% of their position (500.00 shares) of CHEMOMAB THERAPEUTICS LTD. on the open market
Open‑market purchase worth $1.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/21/2022ACC: 0001178913-22-002402
Officer· Executive VP, CFO & COO
Since Nov 2021
+197.38K
Net shares
Net buyer
$1.6K
Total acquired
2
Open market trades
2B · 0S
3
Total transactions
197.38K acquired
Non-Derivative Transactions2
American Depositary Shares
Direct
Shares
+250.00
Price / share
$3.30
Trade value
$825.00
% of position
16.7%
3/16/2022
1.50K→1.75K
American Depositary Shares
Direct
Shares
+250.00
Price / share
$3.25
Trade value
$812.50
% of position
14.3%
3/16/2022
1.75K→2K
Total
Net shares
+500.00
Net value
$1.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares Direct | 3/16/2022 | P · Purchase | +250.00 | $3.30 | $825.00 | 16.7% | 1.50K | 1.75K |
| American Depositary Shares Direct | 3/16/2022 | P · Purchase | +250.00 | $3.25 | $812.50 | 14.3% | 1.75K | 2K |
| Total | +500.00 | $1.64K | ||||||
Derivative Transactions1
Option to Purchase American Depositary Shares
Direct
Converts to
American Depositary Shares
196.88K shares
Shares
+196.88K
Strike price
9.77
Held after
196.88K
Exercisable
—
11/8/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase American Depositary Shares Direct | American Depositary Shares196.88K shares | 11/8/2021 | A · Award | +196.88K | 9.77 | — | 196.88K |